2001
DOI: 10.1016/s0893-133x(01)00241-x
|View full text |Cite
|
Sign up to set email alerts
|

Naltrexone Dampens Ethanol-Induced Cardiovascular and Hypothalamic- Pituitary-Adrenal Axis Activation

Abstract: Alcohol ingestion activates the autonomic nervous system and the hypothalamic-pituitary-adrenal axis. This study examined naltrexone effects on alcohol-induced increases in physiological responses and their association with alcohol liking. Using a within-subjects design, heavy drinking men (N ϭ 19) were maintained on each of three naltrexone doses (0, 50, and 100 mg, p.o.) over an 8-day inpatient stay. Within each naltrexone dose, subjects had three alcohol challenge sessions (none, moderate, high) The brai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

8
54
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 62 publications
(62 citation statements)
references
References 74 publications
8
54
0
Order By: Relevance
“…Alcoholics show an impaired HPA axis function, and there is growing evidence of a link between HPA axis dysregulation and ethanol relapse (Adinoff et al 2005a(Adinoff et al , 2005b(Adinoff et al , 2005cKiefer et al 2006;O'Malley et al 2002). It has been suggested that NTX-induced HPA axis activation suppresses ethanol craving and reduces relapse risk by substituting for the HPA axis-activating effects of ethanol (Kiefer et al 2006;Kreek et al 2002;McCaul et al 2001;O'Malley et al 2002). Consistent with this hypothesis, NTX increased Fos-positive mpPVN cells and nearly doubled the number of activated Fos-positive neurons in the BST-LD and CeA, activation of which is directly linked to recruitment of the mpPVN and HPA axis activation (Buller et al 1998;Dayas et al 1999).…”
Section: Discussionmentioning
confidence: 99%
“…Alcoholics show an impaired HPA axis function, and there is growing evidence of a link between HPA axis dysregulation and ethanol relapse (Adinoff et al 2005a(Adinoff et al , 2005b(Adinoff et al , 2005cKiefer et al 2006;O'Malley et al 2002). It has been suggested that NTX-induced HPA axis activation suppresses ethanol craving and reduces relapse risk by substituting for the HPA axis-activating effects of ethanol (Kiefer et al 2006;Kreek et al 2002;McCaul et al 2001;O'Malley et al 2002). Consistent with this hypothesis, NTX increased Fos-positive mpPVN cells and nearly doubled the number of activated Fos-positive neurons in the BST-LD and CeA, activation of which is directly linked to recruitment of the mpPVN and HPA axis activation (Buller et al 1998;Dayas et al 1999).…”
Section: Discussionmentioning
confidence: 99%
“…One human PET study reported that the cardiac response to alcohol was proportional to the level of alcohol-induced dopamine release (Boileau et al, 2003). Interestingly, cardiac as well as subjective stimulation following alcohol ingestion can be attenuated by Naltrexone, an opiate antagonist that indirectly blocks DA release (King et al, 1997;McCaul et al, 2000;McCaul et al, 2001;Peterson et al, 2006). It has also been demonstrated that only individuals who display an elevated cardiac response to alcohol consume less alcohol following a procedure that reduces dopaminergic neurotransmission (Barrett et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…Human laboratory studies have examined the biobehavioral mechanisms of action of naltrexone Drobes et al, 2004;King et al, 1997;McCaul et al, 2001;Monterosso et al, 2001;Swift et al, 1994;Volpicelli et al, 1995). Results of such studies revealed that naltrexone dampens feelings of alcohol-induced stimulation Swift et al, 1994), decreases ratings of liking of the alcohol (McCaul et al, 2001), causes an increase in self-reported fatigue, tension, and confusion (King et al, 1997), reduces alcohol consumption, and slows down the progression of drinking in a delayed access laboratory paradigm .…”
Section: Introductionmentioning
confidence: 99%
“…Results of such studies revealed that naltrexone dampens feelings of alcohol-induced stimulation Swift et al, 1994), decreases ratings of liking of the alcohol (McCaul et al, 2001), causes an increase in self-reported fatigue, tension, and confusion (King et al, 1997), reduces alcohol consumption, and slows down the progression of drinking in a delayed access laboratory paradigm . More recently, pharmacogenetic studies have focused on the gene coding for m-opioid receptors (ie, OPRM1 gene), which are the primary targets of naltrexone (Goldman et al, 2005;Oslin et al, 2003).…”
Section: Introductionmentioning
confidence: 99%